Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Unique Products Develop, also branded as Anyprint, appears to have been a China-based 3D printing company with activities spanning industrial printing and medical 3D printing. Publicly available sources describe it as having developed a multi-nozzle 3D bioprinter for living cells and biological scaffolds and a multicolor soft-model printer for surgical simulation. The company appears to have positioned itself around bioprinting and digital medical applications rather than as a traditional drug developer. Available evidence suggests it was active in the 2010s, but more recent business databases indicate the company or brand is closed. Because source quality is mixed and primary company materials are limited, pipeline and corporate details should be treated as low-confidence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quingdao Unique.